Brief: Cancer Genetics Files Prospectus Related To Resale Of Upto 5.7 Million Shares Of Common Stock, Including Stock Issuable On Exercise Of Warrants - SEC Filing
Feb 1 (Reuters) - Cancer Genetics Inc CGIX.O :
* CANCER GENETICS FILES PROSPECTUS RELATED TO RESALE OF UPTO
5.7
MILLION SHARES OF COMMON STOCK, INCLUDING STOCK ISSUABLE ON
EXERCISE OF WARRANTS - SEC FILING
* CANCER GENETICS SAYS RESALE OF COMMON STOCK IS BY SELLING
STOCKHOLDERS
Source text for Eikon: [https://bit.ly/39FWki9]
Further company coverage: CGIX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Vyant Bio
See all newsBrief: Vyant Bio Provides Update On Winddown Activities
Brief: Vyant Bio Announces Stockholder Approval Of Plan Of Dissolution
Brief: Vyant Bio Files Form 15 For Voluntary Nasdaq Delisting And SEC Deregistration
Brief: Vyant Bio Announces Filing Of Form 25 For Voluntary Nasdaq Delisting And SEC Deregistration
Brief: Vyant Bio Announces Voluntary Nasdaq Delisting, SEC Deregistration